Status:
COMPLETED
Computerized Screening for Comorbidity in Adolescents With Substance or Psychiatric Disorders
Lead Sponsor:
Center for Psychological Consultation
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
University of Pittsburgh
Conditions:
Psychiatric Disorder
Eligibility:
All Genders
11-17 years
Brief Summary
The KSADS-COMP will facilitate identification of comorbid psychiatric and substance use diagnoses frequently missed in clinical practice, and improve adolescent treatment outcomes. The self-administer...
Detailed Description
This Phase II SBIR grant is a follow-up to the Phase I SBIR grant "Computerized Screening for Comorbidity in Adolescents with Substance or Psychiatric Disorders." During Phase I, parent and adolescent...
Eligibility Criteria
Inclusion
- adolescent between the ages of 11 and 17
Exclusion
- Children will be excluded if they have a diagnosis of mental retardation (IQ \< 70) or a severe psychosis that would impair the child's ability to participate.
Key Trial Info
Start Date :
September 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2018
Estimated Enrollment :
223 Patients enrolled
Trial Details
Trial ID
NCT01866956
Start Date
September 1 2016
End Date
April 30 2018
Last Update
January 27 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hugo W. Moser Research Institute at Kennedy Krieger
Baltimore, Maryland, United States, 21205
2
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15213